Hospital
Cleveland Area Hospital Holdings, INC.
Cleveland Area Hospital Holdings, INC. was paid $4.35M by Medicaid between Jan 2018 and Nov 2024, across 46 billing codes. Its largest line is 99283, emergency room visit (moderate) — 51% of everything it billed.
33Billing provider infoCLEVELAND AREA HOSPITAL HOLDINGS, INC.
CLEVELAND, OK 74020
CLEVELAND, OK 74020
33aNPI1427295872assigned 01/07/2009
33bProvider typeCritical Access Hospital
28Total paid$4.35M
24GClaims56,243
24DCodes billed46
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Oklahoma
Rank by total paid#3 of 40
Median peer was paid$427K
This provider vs. median10×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 6,435 | $437K | |
| 2019 | 5,353 | $465K | |
| 2020 | 3,963 | $331K | |
| 2021 | 8,177 | $652K | |
| 2022 | 15,485 | $1.14M | |
| 2023 | 13,051 | $978K | |
| 2024incomplete | 3,779 | $349K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 51% | 20,048 | 14,676 | $2.21M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 22% | 5,877 | 4,925 | $960K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 2,149 | 1,694 | $515K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.8% | 3,437 | 3,391 | $165K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 2.6% | 1,786 | 630 | $115K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.8% | 3,801 | 2,748 | $77K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 3,153 | 3,004 | $64K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.4% | 449 | 439 | $61K |
| 36415 | Collection of venous blood by venipuncture | <1% | 3,575 | 3,337 | $27K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 446 | 144 | $25K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,732 | 1,715 | $24K |
| 80053 | Comprehensive metabolic panel | <1% | 1,671 | 1,632 | $15K |
34 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,774 | $12K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 194 | $11K |
| 80061 | Lipid panel | <1% | 801 | $9K |
| 71045 | Radiologic examination, chest; single view | <1% | 470 | $7K |
| 87070 | <1% | 766 | $6K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 127 | $6K |
| 80050 | General health panel | <1% | 190 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 240 | $4K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 169 | $4K |
| 81001 | <1% | 1,394 | $4K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 189 | $3K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 13 | $3K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 54 | $2K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 350 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 204 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 26 | $1K |
| 84484 | <1% | 102 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 12 | $1K |
| 83690 | <1% | 163 | $940.92 | |
| 82330 | <1% | 83 | $901.04 | |
| 81025 | <1% | 123 | $855.63 | |
| 86140 | <1% | 199 | $849.33 | |
| 87420 | <1% | 60 | $742.20 | |
| 83605 | <1% | 54 | $534.89 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 58 | $387.79 |
| 82550 | <1% | 56 | $282.52 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 41 | $280.94 |
| 83735 | <1% | 41 | $219.68 | |
| 84439 | <1% | 24 | $198.12 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $189.01 |
| 84481 | <1% | 12 | $180.84 | |
| 85610 | <1% | 29 | $110.78 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 75 | $28.97 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBENTON, EDRED (CEO)